Recent Finacing
Recent Raise
RootPath develops personalized TCR and CAR-T therapies for solid tumors and a platform to monitor, modulate, and steer antitumor immune responses; incubated in Cambridge and Hangzhou.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at RootPath Genomics.
